The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department
NCT ID: NCT02463669
Last Updated: 2020-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
200 participants
OBSERVATIONAL
2016-04-30
2020-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Different Sonographic Modalities and PET-CT in Pediatric Lymphoma
NCT05343676
Lung Ultrasound to Diagnose COVID-19
NCT04368338
A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions
NCT00243698
Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)
NCT04339998
Community-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room Adults
NCT04210102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Point-of-care ultrasound
Enrolled patients will undergo POCUS of the spleen by the treating emergency physician (resident, fellow or attending). Canadian Emergency Ultrasound Society (CEUS) certified residents, fellows and attending physicians will conduct the bedside ultrasonography after receiving specific training for the purposes of this study. The spleen will be assessed using a curved 2-6 Megahertz (MHz) transducer with the participant in the supine position. The cranio-caudal splenic length will be measured and its maximum dimension will be recorded on the standardized study data sheet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inflammatory disorders (eg. sarcoidosis, amyloidosis, systemic lupus erythematosus, Felty syndrome)
* Proliferative disorders (eg. lymphoma, leukemia, essential thrombocytopenia, polycythemia vera)
* Congestive disorders (eg: cirrhosis, portal hypertension, right heart failure, congenital heart disease)
* Chronic haemolytic anemia (eg. sickle cell, thalassemia, hereditary spherocytosis)
* Storage diseases (eg. Gaucher, Niemann-Pick)
* Splenectomy
* Inability to give informed consent
10 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laurie Robichaud
Laurie Robichaud, MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Sainte-Justine
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POCUSIM01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.